Cargando…
A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
PURPOSE: This phase 1 trial aimed to identify the maximally tolerated hypofractionated dose schedule for postoperative radiation therapy (PORT) after radical prostatectomy. Secondary objectives included biochemical control and quality of life (QoL) measures. METHODS AND MATERIALS: Patients were trea...
Autores principales: | Patel, Krishnan R., Rowe, Lindsay S., Schott, Erica, Cooley-Zgela, Theresa, Ning, Holly, Turkbey, Baris, Choyke, Peter, Lindenberg, Liza, Mena, Esther, Pinto, Peter A., Zhang, Qihu, Shih, Joanna, Salerno, Kilian E., Citrin, Deborah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677208/ https://www.ncbi.nlm.nih.gov/pubmed/36420197 http://dx.doi.org/10.1016/j.adro.2022.101024 |
Ejemplares similares
-
Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options
por: Chaurasia, Avinash R, et al.
Publicado: (2020) -
Postprostatectomy Radiation Therapy in the Setting of a Rectal Vascular Malformation
por: Patel, Krishnan R., et al.
Publicado: (2022) -
Successful Stereotactic Body Radiation Therapy for Postbrachytherapy Prostate Recurrence and Penile Bulb Metastasis
por: Citrin, Deborah E., et al.
Publicado: (2021) -
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
por: Rowe, Lindsay S., et al.
Publicado: (2021) -
Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents
por: Czarniecki, Marcin, et al.
Publicado: (2018)